Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight.

Topazian M, Camilleri M, Enders FT, Clain JE, Gleeson FC, Levy MJ, Rajan E, Nehra V, Dierkhising RA, Collazo-Clavell ML, Talley NJ, Clark MM.

Clin Gastroenterol Hepatol. 2013 Feb;11(2):145-50.e1. doi: 10.1016/j.cgh.2012.09.029. Epub 2012 Oct 9.

PMID:
23063681
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study.

Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ, Nehra V, Talley NJ.

Obes Surg. 2008 Apr;18(4):401-7. doi: 10.1007/s11695-008-9442-x. Epub 2008 Feb 20.

PMID:
18286347
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Effects of intramural administration of Botulinum Toxin A on gastric emptying and eating capacity in obese patients.

Foschi D, Lazzaroni M, Sangaletti O, Corsi F, Trabucchi E, Bianchi Porro G.

Dig Liver Dis. 2008 Aug;40(8):667-72. doi: 10.1016/j.dld.2008.02.040.

PMID:
18420471
[PubMed - indexed for MEDLINE]
4.

Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats.

Gui D, De Gaetano A, Spada PL, Viggiano A, Cassetta E, Albanese A.

Aliment Pharmacol Ther. 2000 Jun;14(6):829-34.

PMID:
10848669
[PubMed - indexed for MEDLINE]
Free Article
5.

Effect of botulinum toxin antral injection on gastric emptying and weight reduction in obese patients: a pilot study.

Gui D, Mingrone G, Valenza V, Spada PL, Mutignani M, Runfola M, Scarfone A, Di Mugno M, Panunzi S.

Aliment Pharmacol Ther. 2006 Mar 1;23(5):675-80.

PMID:
16480407
[PubMed - indexed for MEDLINE]
Free Article
6.

Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia.

Tack J, Janssen P, Masaoka T, Farré R, Van Oudenhove L.

Clin Gastroenterol Hepatol. 2012 Nov;10(11):1239-45. doi: 10.1016/j.cgh.2012.06.036. Epub 2012 Jul 17.

PMID:
22813445
[PubMed - indexed for MEDLINE]
7.

The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial.

Choung RS, Cremonini F, Thapa P, Zinsmeister AR, Talley NJ.

Neurogastroenterol Motil. 2008 Mar;20(3):220-7. Epub 2007 Nov 20.

PMID:
18031471
[PubMed - indexed for MEDLINE]
8.

Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study.

García-Compean D, Mendoza-Fuerte E, Martínez JA, Villarreal I, Maldonado H.

Gastroenterol Clin Biol. 2005 Aug-Sep;29(8-9):789-91.

PMID:
16294147
[PubMed - indexed for MEDLINE]
Free Article
9.

Effect on gastric emptying and weight reduction of botulinum toxin-A injection into the gastric antral layer: an experimental study in the obese rat model.

Coskun H, Duran Y, Dilege E, Mihmanli M, Seymen H, Demirkol MO.

Obes Surg. 2005 Sep;15(8):1137-43.

PMID:
16197786
[PubMed - indexed for MEDLINE]
10.

Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study.

Foschi D, Corsi F, Lazzaroni M, Sangaletti O, Riva P, La Tartara G, Bevilacqua M, Osio M, Alciati A, Bianchi Porro G, Trabucchi E.

Int J Obes (Lond). 2007 Apr;31(4):707-12. Epub 2006 Sep 26.

PMID:
17006442
[PubMed - indexed for MEDLINE]
11.

Botulinum toxin A for the treatment of delayed gastric emptying.

Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson DB.

Am J Gastroenterol. 2008 Feb;103(2):416-23. Epub 2007 Dec 5.

PMID:
18070232
[PubMed - indexed for MEDLINE]
12.

Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study.

Delgado-Aros S, Camilleri M, Castillo EJ, Cremonini F, Stephens D, Ferber I, Baxter K, Burton D, Zinsmeister AR.

Clin Gastroenterol Hepatol. 2005 Oct;3(10):997-1006.

PMID:
16234046
[PubMed - indexed for MEDLINE]
13.

Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial.

Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E.

Am J Gastroenterol. 2008 Aug;103(8):2043-50.

PMID:
18803000
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine.

Vazquez Roque MI, Camilleri M, Clark MM, Tepoel DA, Jensen MD, Graszer KM, Kalsy SA, Burton DD, Baxter KL, Zinsmeister AR.

Clin Gastroenterol Hepatol. 2007 Jul;5(7):829-37. Epub 2007 Jun 4.

PMID:
17544870
[PubMed - indexed for MEDLINE]
15.

Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans.

Foxx-Orenstein A, Camilleri M, Stephens D, Burton D.

Gut. 2003 Nov;52(11):1555-61.

PMID:
14570722
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers.

Talley NJ, Camilleri M, Burton D, Thomforde G, Koch K, Rucker MJ, Peterson J, Zinsmeister AR, Earnest DL.

Aliment Pharmacol Ther. 2006 Sep 1;24(5):859-67.

PMID:
16918891
[PubMed - indexed for MEDLINE]
Free Article
17.

Treatment of obesity by endoscopic gastric intramural injection of botulinum toxin A: a randomized clinical trial.

Li L, Liu QS, Liu WH, Yang YS, Yan D, Peng LH, Li LY, Meng JY, Wang XD, Ke M.

Hepatogastroenterology. 2012 Sep;59(118):2003-7. doi: 10.5754/hge11755.

PMID:
22193433
[PubMed - indexed for MEDLINE]
18.

Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients.

Andersen T, Fogh J.

J Hum Nutr Diet. 2001 Jun;14(3):243-50.

PMID:
11424516
[PubMed - indexed for MEDLINE]
19.

Botulinum A toxin injected into the gastric wall for the treatment of class III obesity: a pilot study.

Júnior AC, Savassi-Rocha PR, Coelho LG, Spósito MM, Albuquerque W, Diniz MT, Paixão Ade M, Garcia FD, Lasmar LF.

Obes Surg. 2006 Mar;16(3):335-43.

PMID:
16545166
[PubMed - indexed for MEDLINE]
20.

Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.

Näslund E, King N, Mansten S, Adner N, Holst JJ, Gutniak M, Hellström PM.

Br J Nutr. 2004 Mar;91(3):439-46.

PMID:
15005830
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk